[Antiandrogens in dermatology. (Gravimetric fatdeterminations during the application of cyproterone)].
D015065:17-Hydroxycorticosteroids / Q000627:therapeutic use*; D000152:Acne Vulgaris / Q000188:drug therapy; D000293:Adolescent; D000328:Adult; D000505:Alopecia / Q000188:drug therapy; D000726:Androgen Antagonists; D003864:Depression, Chemical; D012628:Dermatitis, Seborrheic / Q000188:drug therapy; D005260:Female; D006628:Hirsutism / Q000188:drug therapy; D006801:Humans; D008297:Male; D011372:Progestins / Q000627:therapeutic use*; D012627:Sebaceous Glands / Q000187:drug effects; D012629:Sebum / Q000378:metabolism*; D012871:Skin Diseases / Q000188:drug therapy*
D015065:17-Hydroxycorticosteroids; D000726:Androgen Antagonists; D011372:Progestins
Die Antiandrogene in der Dermatologie. (Gravimetrische Fettbestimmungen während Cyproteronanwendung)